These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 7913417)
1. Hypomethylation of the rat aryl sulfotransferase IV gene and amplification of a DNA sequence during multistage 2-acetylaminofluorene hepatocarcinogenesis. Yerokun T; Lyn-Cook BD; Ringer DP Chem Biol Interact; 1994 Jun; 92(1-3):363-70. PubMed ID: 7913417 [TBL] [Abstract][Full Text] [Related]
2. Characterization of a complementary DNA for rat liver aryl sulfotransferase IV and use in evaluating the hepatic gene transcript levels of rats at various stages of 2-acetylaminofluorene-induced hepatocarcinogenesis. Yerokun T; Etheredge JL; Norton TR; Carter HA; Chung KH; Birckbichler PJ; Ringer DP Cancer Res; 1992 Sep; 52(17):4779-86. PubMed ID: 1511441 [TBL] [Abstract][Full Text] [Related]
3. Modulation of hepatic mRNA translation activity and specific expression of arylsulfotransferase IV during acetylaminofluorene-induced rat hepatocarcinogenesis. Yerokun T; Norton TR; Howell B; Ringer DP Cancer Res; 1991 Jan; 51(2):504-9. PubMed ID: 1670761 [TBL] [Abstract][Full Text] [Related]
4. 2-Acetylaminofluorene-mediated alteration in the level of liver arylsulfotransferase IV during rat hepatocarcinogenesis. Ringer DP; Norton TR; Howell BA Cancer Res; 1990 Sep; 50(17):5301-7. PubMed ID: 2386938 [TBL] [Abstract][Full Text] [Related]
5. Evidence of two separate mechanisms for the decrease in aryl sulfotransferase activity in rat liver during early stages of 2-acetylaminofluorene-induced hepatocarcinogenesis. Ringer DP; Howell BA; Norton TR; Woulfe GW; Duffel MW; Kosanke SD Mol Carcinog; 1994 Jan; 9(1):2-9. PubMed ID: 8297481 [TBL] [Abstract][Full Text] [Related]
6. Molecular mechanisms for the regulation of aryl sulfotransferase IV expression during 2-acetylaminofluorene-induced hepatocarcinogenesis in rat. Ringer DP; Yerokun T; Khan AS Chem Biol Interact; 1994 Jun; 92(1-3):343-50. PubMed ID: 8033268 [TBL] [Abstract][Full Text] [Related]
7. Changes in rat liver N-hydroxy-2-acetylaminofluorene aryl sulfotransferase activity at early and late stages of hepatocarcinogenesis resulting from dietary administration of 2-acetylaminofluorene. Ringer DP; Norton TR; Cox B; Howell BA Cancer Lett; 1988 Jun; 40(3):247-55. PubMed ID: 3164251 [TBL] [Abstract][Full Text] [Related]
8. Aryl sulfotransferase IV deficiency in rat liver carcinogenesis initiated with diethylnitrosamine and promoted with N-2-fluorenylacetamide or its C-9-oxidized metabolites. Malejka-Giganti D; Ringer DP; Vijayaraghavan P; Kiehlbauch CC; Kong J Exp Mol Pathol; 1997 Apr; 64(2):63-77. PubMed ID: 9316585 [TBL] [Abstract][Full Text] [Related]
9. Reaction product inactivation of aryl sulfotransferase IV following electrophilic substitution by the sulfuric acid ester of N-hydroxy-2-acetylaminofluorene. Ringer DP; Norton TR; Self RR Carcinogenesis; 1992 Jan; 13(1):107-12. PubMed ID: 1733562 [TBL] [Abstract][Full Text] [Related]
10. Correlation of c-myc overexpression and amplification with progression of preneoplastic liver lesions to malignancy in the poorly susceptible Wistar rat strain. De Miglio MR; Simile MM; Muroni MR; Pusceddu S; Calvisi D; Carru A; Seddaiu MA; Daino L; Deiana L; Pascale RM; Feo F Mol Carcinog; 1999 May; 25(1):21-9. PubMed ID: 10331741 [TBL] [Abstract][Full Text] [Related]
11. The role of epigenetic events in genotoxic hepatocarcinogenesis induced by 2-acetylaminofluorene. Pogribny IP; Muskhelishvili L; Tryndyak VP; Beland FA Mutat Res; 2011 Jun; 722(2):106-13. PubMed ID: 20188851 [TBL] [Abstract][Full Text] [Related]
12. Role of epigenetic and miR-22 and miR-29b alterations in the downregulation of Mat1a and Mthfr genes in early preneoplastic livers in rats induced by 2-acetylaminofluorene. Koturbash I; Melnyk S; James SJ; Beland FA; Pogribny IP Mol Carcinog; 2013 Apr; 52(4):318-27. PubMed ID: 22213190 [TBL] [Abstract][Full Text] [Related]
13. Self-catalyzed irreversible inactivation of rat hepatic aryl sulfotransferase IV by N-hydroxy-2-acetylaminofluorene. Mangold BL; Erickson J; Lohr C; McCann DJ; Mangold JB Carcinogenesis; 1990 Sep; 11(9):1563-7. PubMed ID: 2401045 [TBL] [Abstract][Full Text] [Related]
14. Correlation between S-adenosyl-L-methionine content and production of c-myc, c-Ha-ras, and c-Ki-ras mRNA transcripts in the early stages of rat liver carcinogenesis. Simile MM; Pascale R; De Miglio MR; Nufris A; Daino L; Seddaiu MA; Gaspa L; Feo F Cancer Lett; 1994 Apr; 79(1):9-16. PubMed ID: 7910516 [TBL] [Abstract][Full Text] [Related]
15. Nonlinearities in 2-acetylaminofluorene exposure responses for genotoxic and epigenetic effects leading to initiation of carcinogenesis in rat liver. Williams GM; Iatropoulos MJ; Wang CX; Jeffrey AM; Thompson S; Pittman B; Palasch M; Gebhardt R Toxicol Sci; 1998 Oct; 45(2):152-61. PubMed ID: 9848122 [TBL] [Abstract][Full Text] [Related]
16. Inhibition of sulfotransferase affecting unscheduled DNA synthesis induced by 2-acetylaminofluorene: an in vivo and in vitro comparison. Monteith DK Mutat Res; 1992 Aug; 282(4):253-8. PubMed ID: 1379687 [TBL] [Abstract][Full Text] [Related]
17. Changes in levels of ADP-ribose polymers in rat liver during 2-acetylaminofluorene-induced hepatocarcinogenesis. Kiehlbauch CC; Kosanke SD; Ringer DP Carcinogenesis; 1993 Jul; 14(7):1435-40. PubMed ID: 8330362 [TBL] [Abstract][Full Text] [Related]
18. Effects of the tumor promoter 2-acetylaminofluorene and of 4-acetylaminofluorene on rat liver growth. Gerlyng P; Seglen PO Bull Cancer; 1990; 77(5):461-6. PubMed ID: 2400817 [TBL] [Abstract][Full Text] [Related]
19. GDP-fucose:GM1 alpha 1----2fucosyltransferase is activated in parenchymal cells of rat liver during early stages of N-2-acetylaminofluorene induced hepatocarcinogenesis. Holmes EH Carcinogenesis; 1990 Jan; 11(1):89-94. PubMed ID: 2295130 [TBL] [Abstract][Full Text] [Related]
20. Lack of acetylaminofluorene--DNA adduct formation in enzyme-altered foci of rat liver. Huitfeldt HS; Hunt JM; Pitot HC; Poirier MC Carcinogenesis; 1988 Apr; 9(4):647-52. PubMed ID: 2895693 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]